Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin and E. Coli Nissle in Active Ulcerative Colitis
NCT01772615Phase 4Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- May 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of ciprofloxacin, escherichia coli nissle 1917 in ulcerative colitis (UC), sponsored by Copenhagen University Hospital - Hvidovre. Started May 2011; status: completed.
02
Drugs
ciprofloxacinescherichia coli nissle 1917
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01772615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01772615.